secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001493152-24-011344
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity raises $1M in private placement of Series B Preferred Stock, with option for additional $1M
--------------------------------------------------------------------------------

- Gross proceeds of $1M from sale of 110 Series B Convertible Preferred shares at $9,090.91 each.
- Company has 30-day option to require second closing for additional $1M (110 more shares).
- Series B Preferred Stock: 8% cumulative dividend (15% upon triggering event), initial conversion price $3.50, alternate conversion at 80% of lowest VWAP.
- Registration rights agreement requires filing registration statement within 45 days; failure triggers issuance of 100,000 common shares.
- Voting agreement with certain stockholders to support Nasdaq-required stockholder approval for conversion shares issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/0001493152-24-011344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224011344/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer